A SHOWCASE AND CELEBRATION OF OUR
2024 GRADUATING STARTUPS

Join us on May 9 at NYU Stern School of Business for Endless Frontier Labs’ capstone event, Frontiers 2024. At Frontiers 2024, you’ll have a chance to explore the groundbreaking work of our newly graduated startups through a series of pitch presentations across life sciences, digital tech, and deep tech verticals, as well as a panel discussion featuring industry experts from our distinguished mentor network.

Register Here

Director’s Note

Welcome to Frontiers 2024. We are thrilled that you’ve joined us to celebrate the progress of our 2023-2024 cohort of startups.

At Endless Frontier Labs (EFL), we are dedicated to advancing human welfare through science and technology-based entrepreneurship. Our nine-month program for seed-stage founders provides mentorship from industry leaders, access to investors and customers, and business development support from MBA students in NYU Stern’s top-ranked MBA program.

Despite the strong headwinds facing the venture industry this past year, EFL graduates have continued to thrive. Notably, BreachQuest (Digital Tech ‘23), a cybersecurity company that bolsters enterprises’ incident response mechanisms against cyber attacks was acquired by Resilience, a leading cyber risk management firm, and Haystack Oncology (Life Science ‘23), a cancer detection company, was acquired by Quest Diagnostics in a $450M deal.Since 2019, the EFL process has helped its 183 startup graduates raise$1.83 billion with a combined valuation of $5.04 billion.Based on this number, and other key metrics of accelerator success like fraction of startups that successfully raise, and frequency of high-value startups, the EFL stands without peer among programs that serve deep tech and science based companies.

This year’s cohort of 54 graduating companies were selected from a pool of nearly 1,400 applicants from over 60 countries worldwide.The founders of these startups, with the guidance of EFL mentors, have made excellent progress in building their businesses over the past nine months and are poised to disrupt various industries, including drug discovery, energy, logistics, enterprise security, space, and healthcare delivery. You can explore brief descriptions of each company on our website or in the program booklet.

Frontiers 2024 will feature the latest from these companies in a format that is designed to provide a vantage of the latest in science, technology and industry. Come, join us on May 9 to celebrate EFL’s 2023-24cohort and immerse yourself in a showcase of our collective future.

Deepak Hegde

Founder and Andrew Hamilton Director, Endless Frontier Labs
Seymour Milstein Professor of Strategy, NYU Stern School of Business

PROGRAM

MAY 9, 2024

Welcome Address

Panel: Unlocking the Power of Big Data & Biology

Startup Presentations: Computational and Synthetic Biology Platforms

    Startups:

  • Serinus Bio
  • Quanmol Tech
  • resistanceBio
  • Pando Bioscience
  • Vivtex

View startup details here

Panel: Breakthrough Treatments for Unmet Needs

Startup Presentations: Oncology and Immune Therapies

    Startups:

  • Glytherix
  • Avstera Therapeutics
  • Tezcat Biosciences
  • Calder Biosciences
  • Vector Bioscience
  • Atticus Pharma
  • Matrisome Bio

View startup details here

Startup Presentations: Central Nervous System and Regenerative Medicine

    Startups:

  • 4M Therapeutics
  • Imnewrun
  • Kanna Health
  • Ambulero
  • Eucalyptus Bio
  • InGel Therapeutics

View startup details here

Panel: Frontier Tech Applications and Impact

Startup Presentations: Advanced Materials and Sustainability

    Startups:

  • Strayos
  • BIOWEG
  • GreenPod Labs
  • Soliyarn
  • Cocoon Bioscience
  • Circu Li-ion
  • INAEDIS
  • Direct Kinetic Solutions

View startup details here

Startup Presentations: Automation, Robots, and Rockets

    Startups:

  • Zordi
  • Fire Neural Network
  • Kyber Labs
  • Rocket Propulsion Systems
  • Sinovia Technologies

View startup details here

Startup Presentations: Medical Devices and Diagnostics

    Startups:

  • Cooler Heads
  • Ataraxis AI
  • Oraliva
  • OxiWear
  • Promise Bio
  • NeuroVirt

View startup details here

Networking Lunch

Panel: Digital Health Solutions for Patients & Providers

Startup Presentations: AI for Healthcare Diagnostics and Management

    Startups:

  • Aware Health
  • Knowtex
  • Moody Month
  • SleepScore Labs
    Narrativa

View startup details here

Panel: Enterprise AI and the Future of Work

Startup Presentations: AI for Data Analytics and Cybersecurity

    Startups:

  • Bilby
  • SURF Security
  • Quantum Bridge Technologies
  • DeepKeep
  • Digip
  • Fr0ntierX

View startup details here

Startup Presentations: AI for Enterprise Productivity

    Startups:

  • Synapbox
  • Maestro AI
  • Akool
  • Gigantor
  • Augmenta
  • VESSL AI
  • Vody

View startup details here

Elizabeth Elting Awards & Reception


SPEAKERS

 

Ade Ajanaku
Senior Product Manager at Intuit
Amir Reuveny
CEO of Wesper (EFL Digital Tech ‘20)
Asad Malik
CEO of iRocket (EFL Deep Tech ‘21
Asaf Zviran
Co-Founder & CEO Prism AI Therapeutics (EFL Life Sciences...
Bruce Zetter
Charles Nowiszewski Professor of Cancer Biology, Harvard Medical School
Chris Ho
Director, Vickers Venture Partners
David Fenyö
Professor, Computational Biology, NYU Langone Health
Dillon Baxter
Founder and CEO of PlantSwitch (EFL Deep Tech ‘23)
Elizabeth Elting
Founder and CEO, Elizabeth Elting Foundation & Stern MBA...
Foster Provost
Ira Rennert Professor of Entrepreneurship, Data Science, and Information...
Jill Richmond
GP, Full Stack VC
Laura Kornhauser
Co-founder & CEO, Stratyfy (EFL Deep Tech ‘20)
Mathew Barnett
CEO of UbiquiTx (EFL Life Sciences ‘23)
Nil Gural
Senior Associate, Polaris Partners
Prakrit Jena
Co-Founder and CTO of Lime Therapeutics (EFL Life Sciences...
Rachael-Linn Spooner
VP Strategic Planning, Clinical Digital Solutions, Northwell Health
Rana Al-Hallaq
Partner, Pfizer Ventures and Executive Director, Worldwide Business Development,...
Sarah Dolman
Partner, Recon Strategy
Sebastian Titz
Investment Manager, 3M New Ventures
Seth Neel
Assistant Professor at Harvard Business School
Tarek Ali Zaki
CEO of OncoPrecision (EFL Life Sciences ‘22)
Toby Stuart
Helzel Professor, UC Berkeley-Haas
Vanessa Rissetto
CEO & Co-founder of Culina Health (EFL Digital Tech...


2024 GRADUATES

 

4M Therapeutics

FUNDRAISING

4M Therapeutics is developing targeted therapies for neurological and psychiatric disorders using its living human brain cell drug discovery platform. The lead asset is safer and more potent than lithium, the current standard of care for bipolar disorder.
Agilis Commerce

Agilis improves chemical suppliers' competitive edge by providing digital solutions that launch and scale customer engagement channels to drive sales growth, improve customer experiences, and boost operational efficiency.
Akool

FUNDRAISING

AKOOL is a Generative AI platform for personalized visual marketing and advertising.
Ambulero

FUNDRAISING

Ambulero is advancing new cell and gene therapy products to treat patients with advanced vascular disease and non-healing wounds, where the standard of care is often amputation.
Apricity Health

Apricity Health offers a precision health platform that merges two health verticals, care delivery and drug discovery, to enhance patient care and utilize longitudinal patient data to identify drug resistance drivers and biomarkers for therapeutic development.
Ataraxis AI

Ataraxis AI is developing prognostic and predictive digital diagnostic assays that integrate multi-modal data to deliver accurate, patient-specific predictions about therapeutic outcomes across several diseases, starting with early-stage breast cancer.
ATOMICS

ATOMICS is revolutionizing data storage with small molecules, creating denser, more sustainable, and durable solutions. We enable precise supply chain traceability for complex products like battery cells, semiconductors, and raw materials.
Atticus Pharma

Atticus Pharma is improving the bioavailability and effectiveness of topically applied drugs for a range of indications, including lupus and alopecia, with its proprietary sustained-release technology.
Avol

Avol is a drone delivery service that enables medical centers to deliver blood up to 11x faster for the same cost or less using novel autonomous electric cargo drones.
Avstera Therapeutics

FUNDRAISING

Avstera Therapeutics is a clinical-stage oncology company tackling key immunological challenges seen in the tumor microenvironment with its oral HDAC6 inhibitor for advanced cancer patients who fail to respond to existing therapies.
Aware Health

FUNDRAISING

Aware Health diagnoses wear and tear orthopedic conditions without imaging and treats them without surgery.
Banyan Infrastructure

Banyan Infrastructure simplifies, accelerates, and optimizes sustainable infrastructure financing by offering a climate fintech platform that streamlines the deal life cycle.
Bilby

Bilby predicts, tracks, and decodes government activity worldwide using AI.
BIOWEG

FUNDRAISING

BIOWEG leverages fermentation, materials science, and green chemistry to replace microplastics in cosmetics, personal care, and agricultural coatings using a zero-waste circular process.
BlueWhale Bio

BlueWhale Bio is developing a novel nanoparticle-based technology to enable development of next-generation cell therapies with increased efficacy and manufacturing capabilities to improve access across multiple therapeutic areas.
BreakBio Corp

BreakBio aims to provide personalized cancer medicine for solid tumors through an AI/ML-driven platform by identifying ~30 tumor antigen targets per patient and manufacturing ~30 targeting peptides.
ByteGenie

ByteGenie helps hospitality teams increase sales and cut procurement costs with an AI-powered bloomberg-like data platform that leverages real-time data scraping and standardization to support leads generation, events intelligence, price benchmarking, and supplier intelligence.
Calder Biosciences

FUNDRAISING

Calder Biosciences is developing the next-generation of recombinant protein vaccines with its patented 3D-Vaxlock™ technology, driving increased potency and more durable protection against infectious diseases.
CartaBio

CartaBio's platform uses cell-centric technology with generative AI to spatially resolve cell states in order to enhance therapeutic success. Their lead technology is focused on improving T cell models for immune cell therapy development.
Cellinfinity Bio

Cellinfinity Bio generates novel cell and gene therapies for solid tumors and autoimmune diseases by identifying therapy-enhancing drug targets through large, whole-genome CRISPR screens of CAR-T and CAR-NK cells.
Ceramedix

Ceramedix aspires to treat diabetic retinopathy and other microvascular injury-related diseases by administering subcutaneously a first-in-class anti-ceramide antibody that selectively targets and disrupts endothelial cell injury.
Circu Li-ion

FUNDRAISING

Circu Li-ion enables the economical reuse of battery packs by developing automated upcycling solutions using robotics and AI.
CLIKA

CLIKA makes AI efficient, tiny, and fast on any device by automating model compression and format compilation using a proprietary hardware-aware algorithm.
Cloverleaf Bio

Cloverleaf Bio looks to improve patient outcomes in oncology by inhibiting cancer growth with a single therapeutic molecule using a new platform of engineered tRNA therapeutics.
Coastar Therapeutics

Coastar Therapeutics looks to improve drug delivery for cancer immunotherapies and gene therapies through their proprietary Erythrocyte Derived Membrane (EDM) platform.
Cocoon Bioscience

Cocoon Bioscience produces critical enzymes and proteins using a novel expression system that leverages insect cocoons as natural bioreactors, offering performance and cost advantages over traditional methods.
Cooler Heads

FUNDRAISING

Cooler Heads provides cancer patients and care providers with FDA-cleared products, content, and services for the management of side effects of treatment.
CTGT

CTGT mitigates hallucinations and bias in deep learning models by opening the black box of AI with a platform that significantly reduces compute needs, enabling deployment in regulated sectors.
Cyanotype Bio

Cyanotype Bio is developing an AI-driven discovery and biomanufacturing platform, powered by proprietary plant cell agriculture technology, to unlock the 97% of bioactives and their countless combinations yet to be discovered in the Plant Kingdom.
DataHive

DataHive transforms how data is owned and utilized by empowering individuals and organizations with ownership-powered AI that turns their digital footprint into valuable assets.
dataspan.ai

dataspan.ai enables true automated visual inspection for industrial use cases by creating GenAI-driven data that optimizes computer vision models.
DeepKeep

FUNDRAISING

DeepKeep empowers large corporates that rely on AI, GenAI, and LLM to manage risk and protect growth.
Digip

FUNDRAISING

Digip provides startups and SMEs with an automated trademark filing and protection service that streamlines the trademark protection process.
Direct Kinetic Solutions

FUNDRAISING

Direct Kinetic Solutions strives to decarbonize the energy sector using high-energy-density radioisotopes to create self-sustaining, long-lasting power sources that combine the persistence and reliability of a power plant with the convenience and mobility of a battery the size of a stamp.
DoriNano

DoriNano's novel DNA origami drug delivery platform aims to improve drug stability, targeting, and efficacy. Their nanoparticles load a diverse cargo of vaccines, immunotherapies, siRNA/mRNAs, and more to treat cancer, autoimmune diseases, and infectious diseases.
Elm AI

Elm AI helps companies measure and improve their supply chains' social and environmental impact by providing a platform that calculates risk and compliance faster, cheaper, and more accurately.
Enigma Aerospace

Enigma Aerospace is set to revolutionize military and B2B logistics with long-range, heavy-lift, autonomous aircraft that operate independently of runways.
Eucalyptus Bio

FUNDRAISING

Eucalyptus Bio is enabling the treatment of hundreds of currently unaddressable genetic diseases using its long-range gene editing platform (CRISP-HR) to permanently correct multiple disease causing mutations within an unparalleled genome edit window.
Fenix Commerce

Fenix Commerce optimizes last-mile delivery and returns for eCommerce retailers by offering a platform that enhances customer experience and boosts conversion rates.
Fermbox Bio

Fermbox Bio is a biomaterials company focused on disrupting traditional supply chains reliant on plant, animal, and harsh chemical processes. We harness advanced biotechnology and precision fermentation to produce sustainable materials essential to everyday life.
Fire Neural Network

FUNDRAISING

Fire Neural Network uses AI to detect wildfires, processing lightning data gathered by patented ground-based sensors to identify high-risk lightning and probable ignition points. The hotspots are then validated with a proprietary US-made drone.
Fr0ntierX

FUNDRAISING

Fr0ntierX provides enterprises with cybersecurity and access management by utilizing emerging technologies to secure and encrypt data in all stages, allowing for granular-level data insights and user privacy.
Free Form Fibers

Free Form Fibers produces high purity, and therefore high performance, fiber materials using chemical vapor deposition technology for next generation composites used in a range of critical high tech industries, including aviation, defense, energy, and semiconductors.
Frost Methane

Frost Methane partners with livestock farmers to keep waste methane from the atmosphere and turn it into revenues. This reduces the warming effects caused directly by methane and premature deaths and crop failures caused by methane's contribution to smog.
geCKo Materials

geCKo Materials offers a bio-inspired dry adhesive that is ultra-strong, reusable, and residue-free, detaching without force. This technology lowers costs and energy consumption while enabling new applications in industrial automation, robotic gripping, space, and defense.
Gigantor

FUNDRAISING

Gigantor optimizes artificial intelligence performance for edge mobility devices with a multi-patented circuit-generating system for FPGAs and ASICs.
GlyTherix

FUNDRAISING

GlyTherix is a clinical-stage targeted radiotherapy company developing a first-in-class therapeutic antibody to treat solid tumors expressing Glypican-1 (GPC-1), a cell surface target that occurs within many solid tumors including prostate, bladder & pancreatic cancers.
GreenPod Labs

FUNDRAISING

GreenPod Labs is an Agtech startup developing products to extend the shelf life of fruits and vegetables at ambient temperature during transport and storage.
Helix Earth

Helix Earth is revolutionizing air conditioning with non-invasive retrofit devices that boost commercial AC efficiency by over 50%.
Hoox

Hoox empowers banks and card issuers to engage effectively with their customers by providing a Customer Activation Platform that drives top-of-wallet status and improves card portfolio health.
IDP Pharma

IDP Pharma is developing cancer therapies that target intrinsically disordered proteins and modulate intra-protein interactions with a lead target of cMyc, a key disease driver in 70% of cancers.
iLoF

iLoF aims to improve personalized drug development by creating a digital library of biomarkers and biological profiles using its advanced artificial intelligence and photonics platform to get personalized treatments to patients faster.
IMNEWRUN

FUNDRAISING

IMNEWRUN is developing a novel blood-brain barrier penetrating antibody platform and therapeutic pipeline for patients with brain-related diseases, starting with Alzheimer's disease.
INAEDIS

INAEDIS aims to disrupt pharmaceutical cold-chain logistics by enabling the thermal stabilization of heat- and freeze-sensitive biologics at room temperature, using a technology that converts liquid biologics into room-temperature stable powders with proprietary dehydration equipment.
InGel Therapeutics

FUNDRAISING

InGel Therapeutics is developing bioengineered cell therapies to bring back light to patients suffering from all forms of retinal degeneration and blindness.
Kanna Health

FUNDRAISING

Kanna Health is a clinical-stage biotech looking to bridge the 'intimacy gap' by developing an on-demand solution for premature ejaculation, for which there is currently no FDA-approved treatment.
Knowtex

Knowtex empowers clinicians with voice AI workflows to generate accurate notes, coding, and orders tailored by specialty to clinical conversations, empowering clinicians to save hours each day, capture revenue leakage, and focus on patient care.
Koi Biotherapeutics

Koi Biotherapeutics' CAR-Enhancer platform uses a novel protein therapeutic that selectively binds to any CAR T-cell therapy to enhance activity, prevent exhaustion, and promote development into memory cells.
Kyber Labs

Kyber Labs tackles manual labor shortages with a robotic manipulation platform designed for AI-based controls, leveraging novel and unique artificial fiber-based actuators that mimic human muscle, thus enabling natural movements not possible with traditional systems.
LATERAL.systems

LATERAL.systems is an AgTech startup developing an edge-based platform for monitoring water quality and atmospheric conditions in Controlled Environment Agriculture, as well as commercial aquaponics and hydroponics farms.
Libera Bio

Libera Bio is developing a novel class of cancer therapeutics using their proprietary nanoparticle technology to deliver large antibodies to intracellular targets.
Lore Machine

Lore Machine transforms story text into immersive multimedia experiences by providing an AI-native web application for creative content.
MabSwitch

Mabswitch is developing regulatable antibody therapies using a novel affinity-switch technology to treat cancer, autoimmune, and infectious diseases with enhanced efficacy and control over side effects
Maestro AI

FUNDRAISING

Maestro increases development team velocity and alignment by automatically creating status updates, updating documentation, and helping people stay in sync through a generative AI powered platform.
Matrisome Bio

Matrisome Bio is leveraging a new target, the disease-associated extracellular matrix, to develop nanobodies for highly targeted delivery of therapeutic payloads to a range of chronic disease sites, including tumors, metastases, and fibrotic lesions.
Merlin Biotech

Merlin looks to improve treatment for pediatric sarcomas, adult solid cancers, and other difficult to treat cancers by delivering potent immunotherapy using its first-in-class mRNA technology.
Modulate Bio

Modulate Bio is developing fine-tuned neuro-medicines for GABAA-linked CNS disorders (e.g., essential tremor, epilepsy, and anxiety) using its next-generation platform that can elucidate how compounds interact with brain receptors.
Moody Month

FUNDRAISING

Moody improves mental and physical health for women by connecting their hormone health data with actionable support.
Navaflex

NavaFlex is pioneering flexible, safe, washable batteries (10 mAh to 2000 mAh) that integrate into fabrics, enabling a new generation of smart clothing and wearables for health, safety, and fashion.
NeuroVirt

FUNDRAISING

NeuroVirt improves the road to recovery for patients with neurological conditions by combining immersive virtual reality, sensor technology, and AI-driven games to assess and train movement rehabilitation whilst controlling for real-time movement quality and projecting kinematic data for clinical monitoring.
NightVision Security

NightVision streamlines security testing in development by providing frictionless software that integrates security earlier into the DevOps process, reducing time to market.
Olfera

Olfera utilizes a novel technology that models the three-compartment olfactory system to enable screening and development of drugs that can traverse the olfactory epithelium to be delivered directly to the brain.
OraLiva

FUNDRAISING

OraLiva is reshaping the future of oral health through early detection with its AI-based, first-in-class, clinically validated oral cancer adjunctive test.
OxiWear

FUNDRAISING

OxiWear develops wearables for continuous oxygen monitoring, delivering low-oxygen alerts during still and motion to enhance safety, reduce healthcare costs, and save lives for those vulnerable to silent hypoxia.
Page Technologies

PAGE Technologies offers an affordable, all-in-one environmental monitoring platform that continuously tracks key parameters such as pH, temperature, salinity, and nutrient concentrations in soil and water, providing real-time insights through a compact, portable system.
Pando Bioscience

FUNDRAISING

Pando Biosciences is a synthetic biology company transforming active pharmaceutical ingredients production by developing high-performance enzymes using Generative AI and its proprietary ultra-high-throughput screening platform, ultimately reducing costs and improving productivity.
Plantibodies

Plantibodies is developing a novel, plant-based oral encapsulation method for targeted delivery of biologics into the gastrointestinal tract for the treatment of GI diseases such as colorectal cancer.
PLATMA

PLATMA AI empowers small and medium-sized enterprises by providing a no-code business automation platform that utilizes AI to generate web applications from plain English requirements.
Promise Bio

Promise Bio is uncovering new biological insights to advance precision medicine for immune-mediated diseases by performing broad epiproteomic analysis using a proprietary computational platform.
Propitious Technologies

Propitious Technologies is transforming heavy vehicle transportation by reducing costs, increasing range, and lowering emissions with our patent-pending bolt-on suspension system.
Quanmol Tech

FUNDRAISING

QuanMol Tech is establishing a new standard for in-silico drug discovery with its AI-powered precision drug design platform that determines optimal compounds from structural information over traditional trial-and-error based processes.
Quantum Bridge Technologies

FUNDRAISING

Quantum Bridge Technologies develops and commercializes cryptographic solutions to protect government and enterprise clients against quantum computer attacks.
Rasayana Therapeutics

Rasayana Therapeutics is utilizing the gut-organ axis to develop gut-targeted treatments for chronic diseases. Their lead candidate is a first-in-class, gut-restricted biologic that inhibits inflammation and intestinal permeability in ulcerative colitis.
REEV

REEV is revolutionizing mobility for millions with walking disorders through AI-powered exoskeletons.
Rejuvenation Technologies

Rejuvenation Technologies looks to improve quality of life and the human lifespan by treating chronic pulmonary, hepatic, and hematopoietic diseases through telomere extension using its mRNA delivery technology.
Relyion Energy

Relyion Energy is an AI-driven company that optimizes battery life and performance using physics-based intelligence and smart controls.
resistanceBio

FUNDRAISING

resistanceBio is pioneering a new therapeutic modality to overcome cancer drug resistance by mapping how cancer will evolve to resist therapies using billions of cells in long-term evolution.
Revolv3

Revolv3 increases revenue and reduces churn for card-on-file merchants by delivering a payment optimization platform that uses AI and ML for higher approval rates at lower costs.
RISE Robotics

RISE Robotics develops net-zero mobile industrial machines with proprietary technology that delivers three times the speed and efficiency of traditional hydraulics, enabling the electrification of previously uneconomical heavy machinery.
Robochef

Robochef develops and implements robotic food automation solutions to address labor challenges in the food service industry.
Rocket Propulsion Systems

FUNDRAISING

Rocket Propulsion Systems manufactures affordable and scalable rocket engines and space vehicles that dramatically improve the economics of small and medium payload launch operations.
Safe YOU | Impact Innovations Institute

Safe YOU empowers women and disrupts violence by providing a comprehensive tech solution with a mobile app and AI analytics to support safety and inform policymakers.
Script Biosciences

Script Biosciences is developing a dual-therapy platform that combines a CRISPR-based gene editing system with lipid nanoparticle carriers for delivery of genetic materials to target organs, including the brain.
SEED Therapeutics

SEED Therapeutics utilizes novel Molecular Glue compounds that facilitate ubiquitination and targeted protein degradation of previously undruggable proteins in cancer, neurodegenerative disease, and more.
Sensible Biotechnologies

ExoDiscovery develops and services blood plasma-based, ultra-sensitive cancer diagnostics for pancreatic and lung cancers for Minimal Residual Disease (MRD) monitoring and screening.
Serentrix

Serentrix aims to develop novel, non-opioid pain relief compounds that selectively antagonize a unique nociceptor pathway, aiming to address pain and inflammation associated with the management of dry eye, IBD, acute pancreatitis, and more.
Serinus Bio

FUNDRAISING

Serinus Bio is designing precision medicine drugs to overcome cancer treatment resistance with its active-learning AI platform that identifies shared vulnerabilities across resistant patient populations that are otherwise too small or insular to motivate drug development programs.
Simulacra SDS

Simulacra Synthetic Data Studio enhances consumer and market research by generating predictive real-time synthetic data and causal scenario modeling through advanced AI techniques.
Sinovia Technologies

FUNDRAISING

Sinovia manufactures printed light film to create next-generation interfaces for smart products using newspaper printing techniques and a proprietary materials technology.
SleepScore Labs

FUNDRAISING

SleepScore Labs provides data and insights to improve health through better sleep.
Smabbler

Smabbler Graph RAG helps AI developers build accurate models faster by providing an as-a-service solution for automatic knowledge graph creation and context enrichment.
Soliyarn

FUNDRAISING

Soliyarn creates smart fabrics sustainably, using a variety of functional coatings that are applied with a proprietary chemical vapor deposition process (CVD). The process preserves the innate characteristics of the fabric and eliminates the use of water in the finishing processes.
Spectronn

Spectronn delivers trusted geospatial data intelligence by leveraging its proprietary explainable and generative AI platform.
SpruceID

SpruceID empowers users to control their data by securely issuing digital identity and credentials, allowing platforms to request access to users’ data vaults.
Strayos

FUNDRAISING

Strayos helps Mining and Cement companies sustainably extract raw minerals and materials by providing machine vision sensing and a visual AI platform to optimize the Drilling, Blasting, and Crushing process to improve the mine’s efficiency, profitability, and sustainability.
Sunchem

Sunchem is developing nano-leaching and nano-filter technologies for precise separation of critical metals. These innovations provide a superior, environmentally friendly alternative to traditional methods used in water purification and energy sectors.
SURF Security

FUNDRAISING

SURF provides secure, productive, and agile browsing experiences for organizations by consolidating multiple endpoint security tools using the SURF Zero-Trust Browser that securely connects users to their web apps.
Suyana Climate Insurance

Suyana enhances climate resilience by making insurance more accurate, accessible, and affordable using advanced machine learning and digital technologies.
syd.life

syd™ enhances quality of life by improving organizational health, productivity, and retention and providing personalized recommendations using an AI-powered platform that leverages science-backed solutions.
Synapbox

FUNDRAISING

Synapbox helps brands test their messaging and creative content by conducting automated interviews and collecting biometric and rational feedback from consumers online.
SyntheX

SyntheX is utilizing a novel cell-engineering strategy to target previously inaccessible disease-causing proteins by leveraging protein-protein interaction inhibition and protein degradation.
Telness Tech

Telness Tech streamlines mobile operator launches and operations by providing fully automated end-to-end software solutions that enhance customer satisfaction and reduce costs.
Tessel Bio

Tessel Bio's AI-driven drug discovery platform utilizes unique patient-derived tissues to model chronic disease. Their current pipeline aims to target neutrophilic inflammation and tissue remodeling in COPD, IBD, and more.
Tezcat Biosciences

FUNDRAISING

Tezcat Biosciences is developing a receptor-independent drug delivery technology to provide treatment alternatives for patients harboring RAS-activated cancers.
The Rubic

The Rubic’s AI-powered robotic system autonomously handles case picking, put-away, and replenishment, integrating into existing facilities with no need for upgrades or downtime.
Trust Science

Trust Science helps lenders find overlooked "Invisible Prime™" borrowers by utilizing its AI-powered Credit Bureau 2.0®, enabling access to credit despite low FICO scores.
Vector Bioscience

Vector Bioscience is developing a machine learning supported RNA delivery platform for any existing cargo, enabling precision-targeted delivery to tumors with controlled release, driving improved efficiency and minimized side effects.
Verne

Verne reduces the cost of hydrogen transport from producers to end-users by offering innovative storage technology that maximizes hydrogen density.
VESSL AI

FUNDRAISING

VESSL AI accelerates AI development at scale by building robust MLOps infrastructure.
Vitro3D

Vitro3D is developing a software-enabled manufacturing platform that is 100 times faster than traditional additive methods, enabling on-demand production of high-resolution parts that cannot be achieved with injection molding.
Vivtex

Vivtex is enabling the development of new oral drugs for medications that currently require painful, inconvenient needle injections using its high-throughput, gut-on-a-chip platform supported by its proprietary AI algorithms and formulations.
Vody

Vody empowers e-commerce companies to boost sales and save costs by enhancing recommendation systems and surfacing relevant content using multimodal ML classification and generative models that harness diverse data sets.
VoicePlug

VoicePlug empowers voice commerce for businesses by providing Voice-AI solutions that personalize customer interactions and enhance revenue opportunities.
Werewool

Werewool is a biotechnology company transforming the fashion industry by creating performance materials with intrinsic color and functionality. This approach eliminates the dyeing process and plastics from the textile supply chain, making it more compatible with nature.
WORMSENSING

WORMSENSING has developed a durable, high-performance vibration sensor that meets the needs of machine manufacturers and asset managers, providing reliable data for predictive maintenance and optimized operations.
Wright Electric

Wright Electric aims to transform U.S. aviation by developing sustainable all-electric aircraft, using advanced batteries, efficient propulsion systems, and energy-dense generators to drive clean aviation forward.
Youverify

Youverify fights financial crime and fraud by using machine learning to blend authoritative and public data with explainable AI and real-time monitoring.
ZORDI

FUNDRAISING

Zordi uses AI and intelligent robots to develop automated greenhouses with the goal of feeding the world with high-quality, sustainably-grown produce. Currently operating two farms in New York and New Jersey.

MISSION

To transform breakthrough science into societal impact. We seek to advance human welfare by supporting founders of science and technology-based startups.

PROGRAM

Founded at New York University’s Stern School of Business, Endless Frontier Labs guides founders through a performance-based mentoring process over the course of nine months. Endless Frontier Labs is open to pre-Series A science and technology startups. The program is suitable for founders from around the world seeking connections to the thriving New York startup ecosystem or U.S. markets. Founders are not required to have a New York University affiliation and do not have to relocate to New York. The program is completely free for participating founders and does not take any equity in startups.

PARTNERS

EFL is supported by the program’s Founding Partners Elizabeth Elting, Stan Moss, and Glenn Krevlin. EFL’s corporate partners support the program and its participating startups through a variety of services.